2012 - Europe Direct Iasi
2012 - Europe Direct Iasi
2012 - Europe Direct Iasi
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
EUROINVENT <strong>2012</strong><br />
4.32.<br />
Title The cellular therapy methods<br />
Authors<br />
ABABII Ion, NACU Viorel, CIOBANU Pavel, GHIDIRIM<br />
Gheorghe, NACU Ludmila, REVENCU Tatiana, MOCAN Elena<br />
Institution<br />
State Medical<br />
Testemiţanu”<br />
and Pharmaceutical University „Nicolae<br />
Patent no.<br />
MD 3556; MD 3998; MD 3338; MD 1270; MD 834; MD 1168;<br />
MD 1585; MD 191Z; MD 258Y; MD 192.<br />
Experimental and clinical data of utilization of the cell grafts and<br />
composites to stimulate the bone regeneration and rehabilitation<br />
Description<br />
of patients with pseudoarthrosis and bone defects have showed<br />
the efficacy of treatment. Also experimental studies showed<br />
good results and perspective to treat the degenerative and<br />
inflammatory diseases in surgery, otolaryngology and urogynecology.<br />
4.33.<br />
METHOD OF VACCINATION AGAINST VIRAL<br />
Title<br />
HEPATITIS B IMMUNOCOMPROMISED PERSONS<br />
Authors Ig. Spînu, C. Spînu, M. Isac, V. Guriev, O. Sajen, P.Chintea<br />
Institution National Center for Public Health, Republic of Moldova<br />
Patent no. MD a 2011 000 06<br />
The use of autohton plant origin medicinal products (Mestim,<br />
Pavstim, Pacovirina) as adjuvant with viral B hepatitis vaccine<br />
administrated patients with renal dialisis treatment with<br />
Description<br />
increased risks of infection diseases, reduces the number of nonrespondente<br />
the vaccine persons, with increase of immunity<br />
level.<br />
4.34.<br />
METHOD OF INFLUENZA AND OTHER ACUTE VIRAL<br />
Title<br />
RESPIRATORY INFECTIONS PROPHYLAXIS<br />
Authors C.Spînu, P. Scoferţa, Ig. Spînu, Angela Roşca<br />
Institution National Center for Public Health, Republic of Moldova<br />
Patent no. MD 3120, 3770<br />
The administration of the autohton product named persons of<br />
different ages, in particular with increased risk of flu illness in<br />
preepidemic, epidemic, (pandemic) and postpandemic periods,<br />
significantly reduce the number of illnesses and postflu<br />
Description<br />
complications in particular: bronhiolotes, brinhopneumonia and<br />
pneumonia. Pacovirin in particular is recommended people with<br />
compromise immune status and those who have absolute and<br />
temporary contra-indications to vaccination.<br />
Class 4<br />
89
Change language